Showing results (1401-1410 of 1,490) with videos related to

Sort By:
Pageof 149
Journal of Immunological Methods|August 23, 2017
Establishing tools for early diagnosis of congenital toxoplasmosis: Flow cytometric IgG avidity assay as a confirmatory test for neonatal screeningAline de Castro Zacche-Tonini, Giuliana Schmidt França Fonseca, Laura Néspoli Nassar Pansini de Jesus, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2022
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 TrialMaria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino, et al.
Oncotarget|April 21, 2017
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancerAranzazu Fernandez-Martinez, Tomás Pascual, Giuseppe Perrone, et al.
International Journal of Medical Sciences|April 16, 2021
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS TrialEriseld Krasniqi, Laura Pizzuti, Maria Rosaria Valerio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD TrialFrancois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, et al.
Lung Cancer (Amsterdam, Netherlands)|December 30, 2019
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patientsMaria Lucia Reale, Rita Chiari, Marcello Tiseo, et al.
Journal of Thoracic Disease|September 13, 2024
Effect on post-operative pulmonary complications frequency of high flow nasal oxygen versus standard oxygen therapy in patients undergoing esophagectomy for cancer: study protocol for a randomized controlled trial-OSSIGENA studyCristian Deana, Massimo Vecchiato, Danila Azzolina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
A multilocus technique for risk evaluation of patients with neuroblastomaInge M Ambros, Bettina Brunner, Gerhard Aigner, et al.
Journal of Immunological Methods|November 24, 2015
IgA and IgG1 reactivities assessed by flow cytometry mirror clinical aspects of infants with ocular congenital toxoplasmosisLaura Néspoli Nassar Pansini de Jesus, Aline de Castro Zacche Tonini, Geisa Baptista Barros, et al.
Pageof 149